Follow the people · Insider

HS

Hunter C. Smith

Insider · Chief Financial Officer · RYTM

Hunter C. Smith files insider transactions with the SEC as a chief financial officer of Rhythm Pharmaceuticals (RYTM). We hold 8 disclosed purchases and sales filed since 2 April 2015, 1 of them in the last 90 days.

  • Files forRYTM
  • Disclosed buys and sells8 in all, 1 in the last 90 days
  • Last disclosure1 September 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 14 February 201831 August 2026Chief Financial Officer · Rhythm Pharmaceuticals (RYTM)176 Form 4 lines · source: SEC Form 4
  • Filed 12 November 202122 June 2023Director · Aeglea BioTherapeutics (AGLE)3 Form 4 lines · source: SEC Form 4
  • Filed 31 March 201530 December 2019Director · Genesee & Wyoming (GWR)25 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.